BioCryst Reports Fourth Quarter and Full Year 2016 Financial Results

Go back to BioCryst Reports Fourth Quarter and Full Year 2016 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.69 +0.03 (0.31%)
Previous Close $9.66    52 Week High $10.98 
Open $9.72    52 Week Low $1.63 
Day High $9.91    P/E N/A 
Day Low $9.65    EPS $-0.68 
Volume 608,633